ArticleBMC cardiovascular disorders2026

Early serum TIMP-2 as a biomarker for 90-day chronic kidney disease after percutaneous coronary intervention in ST-elevation myocardial infarction: a prospective cohort study.

Miras Mugazov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.